Welcome to our dedicated page for Monroe Capital SEC filings (Ticker: MRCC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Monroe Capital’s dividend coverage or spotting non-accrual loans shouldn’t require combing through hundreds of pages. Investors usually start with the 10-Q to confirm net investment income and the 8-K that announces each dividend, then pivot to Form 4s before earnings. This user journey is exactly why we built Stock Titan’s SEC hub for Monroe Capital Corporation.
Every document—whether the Monroe Capital quarterly earnings report 10-Q filing or an unexpected Monroe Capital 8-K material events explained—hits our platform in real time. Our AI-powered summaries translate leverage covenants, portfolio risk tables and management commentary into plain English. Need to trace Monroe Capital insider trading Form 4 transactions or set alerts for Monroe Capital Form 4 insider transactions real-time? One click shows who bought or sold, at what price, and how it lines up with upcoming dividends. You’ll also find the Monroe Capital proxy statement executive compensation distilled so compensation ratios are clear without scrolling through schedules.
Because Monroe Capital is a BDC, its filings reveal nuances many lenders don’t disclose. Our AI highlights the loan-level data buried in the Monroe Capital annual report 10-K simplified and delivers a concise Monroe Capital earnings report filing analysis right next to the source pages. The result: Monroe Capital SEC filings explained simply for professionals who value speed and accuracy. Use our tools for monitoring Monroe Capital executive stock transactions Form 4, comparing quarter-over-quarter credit metrics, and understanding Monroe Capital SEC documents with AI—all without downloading a single PDF.
Monroe Capital Corporation (MRCC) and Horizon Technology Finance Corporation (HRZN) agreed on August 7, 2025 to combine in a two-step transaction in which MRCC will first sell its investment assets to Monroe Capital Income Plus Corporation (MCIP) for cash at fair value and then merge into HRZN.
The exchange of MRCC shares for HRZN shares will use an Exchange Ratio based on each company’s net asset value calculated as of a Determination Date no earlier than 48 hours before closing; no fractional HRZN shares will be issued. Closing is anticipated in the fourth quarter of 2025 and is subject to stockholder approvals, regulatory clearances (including Hart-Scott-Rodino), registration statement effectiveness and other customary conditions. HRZN’s advisor agreed to a $4.0 million fee waiver, paid at $1.0 million per quarter for four quarters, and the agreements include termination fee provisions (approximately $11.0 million and $5.4 million in specified scenarios).
Monroe Capital Corporation will release financial results for the second quarter ended June 30, 2025 on Monday, August 11, 2025, after the close of market trading, according to a press release attached as Exhibit 99.1.
The disclosure is furnished under Regulation FD in Item 7.01 and is expressly noted as being furnished rather than filed for purposes of Section 18 of the Exchange Act; the Form 8-K includes the press release exhibit and is signed by Lewis W. Solimene, Jr., the company’s Chief Financial Officer and Chief Investment Officer.
Monroe Capital Corporation (MRCC) held its 2025 virtual annual meeting on June 17, 2025, where stockholders voted on two key proposals:
Proposal 1 - Director Elections: Stockholders elected two Class I directors to serve until 2028:
- Thomas J. Allison: Received 8,906,506 votes in favor, 2,345,703 withheld
- Robert S. Rubin: Received 9,118,542 votes in favor, 2,133,667 withheld
Proposal 2 - Below NAV Stock Sales: Shareholders approved the company's proposal to sell shares below net asset value over the next twelve months, subject to Board approval. The measure passed with:
- Including affiliate shares: 8,793,403 for, 2,036,074 against
- Excluding affiliate shares: 7,979,467 for, 2,036,074 against
FAQ
What is the current stock price of Monroe Capital (MRCC)?
What is the market cap of Monroe Capital (MRCC)?
